Clinical Trials Browser

Phase 2 × Small Cell Lung Carcinoma × Bendamustine Hydrochloride × Clear all

NCT00984542 2014-03-12

Bendamustine as Second-Line Therapy in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer

Phase 2 Completed

50 enrolled 11 charts

Lung Neoplasms, Small Cell Lung Carcinoma

NCT00168922 2006-04-27

Study to Determine the Efficacy of Bendamustin in Patients With Recurrent Small Cell Lung Cancer (SCLC)

Phase 2 Unknown

Small Cell Lung Carcinoma